Vaccine Development
Nanotechnology for treatment of complex diseases is focus of review
Published in Vaccine Weekly, September 13th, 2006
According to that article, "The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade."
"Although...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-09-13)
More Articles from Vaccine Weekly
- Dengue Vaccine
Live attenuated tetravalent dengue vaccine was safe, effective in Thai children - Malaria Vaccine
Malaria vaccine RTS,S/AS02A is safe and immunogenic in Kenyan adults - Pneumococcal Vaccine
Cost-effectiveness of 7-valent pneumococcal conjugate vaccine was evaluated - Schistosomiasis Vaccine
Schistosoma mansoni tetraspanins protect against schistosomiasis - Vector Development
Dendritic cationic lipids with charged headgroups provide efficient gene delivery - Adrenocortical Cancer
Adrenocortical carcinoma immunotherapy elicits angiogenic stability but not clinical improvement - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
